2012
DOI: 10.1016/j.ijpharm.2012.03.054
|View full text |Cite
|
Sign up to set email alerts
|

Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
58
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 116 publications
(64 citation statements)
references
References 34 publications
1
58
0
Order By: Relevance
“…16,17 Nevertheless, both rectal formulations exhibited a high absolute bioavailability of more than 28%, which could be attributed to a combination of various factors including excellent appreciable gel strength, high mucoadhesive force, and nanosized spherical particles that would facilitate the internalization. 13,14 This bioavailability is nearly 10-fold higher than that of the orally administered DCT, as we reported previously. 29 In the same study, we reported a 17% increase in bioavailability of the drug by DCT-loaded self-nanoemulsifying drug delivery systems (oral), which was the highest reported value until this point in time.…”
supporting
confidence: 70%
See 1 more Smart Citation
“…16,17 Nevertheless, both rectal formulations exhibited a high absolute bioavailability of more than 28%, which could be attributed to a combination of various factors including excellent appreciable gel strength, high mucoadhesive force, and nanosized spherical particles that would facilitate the internalization. 13,14 This bioavailability is nearly 10-fold higher than that of the orally administered DCT, as we reported previously. 29 In the same study, we reported a 17% increase in bioavailability of the drug by DCT-loaded self-nanoemulsifying drug delivery systems (oral), which was the highest reported value until this point in time.…”
supporting
confidence: 70%
“…[1][2][3] However, critical drawbacks, including low aqueous solubility (5 µg/mL, highly lipophilic nature) and poor oral bioavailability (~5%, high first pass metabolism and p-glycoprotein efflux transporter/Rectal administration of the drug in a suitable dosage form remains a viable alternative to oral and intravenous (IV) administration in order to effectively counter the drawbacks and increase the therapeutic profile of DCT. 12,13 We recently reported enhanced bioavailability and anti-tumor potential of DCT by incorporation of thermosensitive and bioadhesive nanomicelles. Owing to appreciable bioadhesive interaction with rectal mucosa, the liquid suppository substantially increased the therapeutic concentration of the drug in the blood circulation and remarkable tumor regression was observed with no overt signs of drug or carrier related toxicity.…”
Section: Introductionmentioning
confidence: 99%
“…This drug presents a very low aqueous solubility (0.01 mg/mL), an octanol-water partition coefficient (logP) of 2.60 and low bioavailability, therefore, it has been classified as Class II drug according to Biopharmaceutics Classification System (BCS) (6,7). Poor bioavailability of this drug may leads to local toxicity at the site of aggregation and hinders reaching desired therapeutic effects (7).…”
Section: Figurementioning
confidence: 99%
“…Poor bioavailability of this drug may leads to local toxicity at the site of aggregation and hinders reaching desired therapeutic effects (7). Taking into consideration the physicochemical properties and poor bioavailability of nimesulide, it can be a good candidate for transdermal drug delivery as an alternative to oral route of its delivery.…”
Section: Figurementioning
confidence: 99%
“…The advantages of dialysis over other methods are in the ease of sampling and replacement of receptor media due to the physical separation of the formulation (by semipermeable dialysis membrane) from the receptor media. However, it is important to emphasize that non-critical interpretation of the obtained results can lead to flawed conclusions about the kinetics of drug release from the colloidal carriers [40,41] and other formulation types [42][43][44][45][46]. The presence of the drug in the receptor medium is the result of drug release from the carrier to the continuous phase in the donor compartment and diffusion of the drug through the membrane from the donor to the receptor compartment.…”
Section: Membrane Diffusion Methodsmentioning
confidence: 99%